Saphnelo is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy.
Saphnelo is the first and only SLE treatment to target type 1 interferon (IFN-1) activity.
Based on three clinical studies, when added to your Lupus treatments, Saphnelo may help reduce disease activity and reduce oral steroid use.
Saphnelo is administered as an intravenous infusion over a 30-minute period every 4 weeks.
Potential Side Effects
The most common side effects of Saphnelo include upper respiratory infections, bronchitis, infusion reactions, shingles (herpes zoster), and cough. Saphnelo can lower the ability of your immune system to fight infections. You may be at a higher risk of developing respiratory infections and shingles (herpes zoster) during treatment with Saphnelo. Serious allergic reactions can happen during or after you get your Saphnelo infusion. Saphnelo may reduce the activity of your immune system. Medicines that affect the immune system may increase your risk of certain cancers.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Saphnelo website.
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP